Research
June 7, 2011
HIV/AIDS at 30
Emory a hub for discovery, prevention and treatment
As AIDS reaches its 30th anniversary, Emory physicians, scientists and educators continue to play a key role in prevention, research and treatment.
From inventing some of the most successful HIV/AIDS drugs, to developing and testing promising vaccines, conducting clinical trials, leading behavioral and prevention research and treating thousands of patients, Emory has been a leader in fighting this challenging global disease from the earliest days of the epidemic.
Emory's newest project displays state HIV/AIDS prevalence rates. AIDSVu is a new interactive online map that provides the most detailed publicly available view of the number of people living with an HIV diagnosis in the United States by state and county.
AIDSVu features data obtained from the U.S. Centers for Disease Control and Prevention, and compiled by researchers at Rollins School of Public Health. It is the first online tool to link state and county-level HIV prevalence data with local HIV testing sites, information about state AIDS drug assistance programs and estimates of the percentage of HIV diagnoses that are made late in the course of the disease.
One of the pioneers in AIDS research and health care is James Curran, dean of Emory's Rollins School of Public Health. Curran recently received the 2011 Ryan White Distinguished Leadership Award for his lifetime of significant contributions to AIDS prevention, including leading the early research and prevention efforts of the CDC after the first reported cases of the impending epidemic.
Watch a series of videos of Curran reflecting on HIV/AIDS 30 years on.
Meet more researchers on the forefront of HIV/AIDS vaccine research at Emory.
For a comprehensive view of Emory's HIV/AIDS efforts, including magazine articles, news releases, video and faculty expertise, see http://bit.ly/aids30emory.
